Prevention of atrial fibrillation following cardiac surgery: Basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning

Pharmacology and Therapeutics

Volumn 118, Issue 1, 2008, Pages 104-127

  Rodrigo, Ramón ^a   Cereceda, Mauricio ^b   Castillo, Rodrigo ^a   Asenjo, René ^b   Zamorano, Jaime ^b   Araya, Julia ^a   Castillo Koch, Rodrigo ^b   Espinoza, Juan ^b   Larraín, Ernesto ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Myocardial preconditioning; n 3 PUFA; Oxidative stress; Postoperative atrial fibrillation; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMIODARONE; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CARVEDILOL; CORTICOSTEROID; CYCLOSPORIN A; DEFEROXAMINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; FISH OIL; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METOPROLOL; PLACEBO; PREDNISONE; PROPRANOLOL; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; UNINDEXED DRUG; XANTHINE OXIDASE;

ANTIARRHYTHMIC ACTIVITY; BRADYCARDIA; CARDIOPULMONARY BYPASS; CARDIOVERSION; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE PREDISPOSITION; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; HUMAN; INCIDENCE; LEUKOCYTOSIS; LIPID PEROXIDATION; LUNG TOXICITY; META ANALYSIS; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ANIMALS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; REACTIVE OXYGEN SPECIES; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 42649094130     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2008.01.005     Document Type: Review

References (343)

1. Abete P., Ferrara N., Cacciatore F., Sagnelli E., Manzi M., Carnovale V., et al. High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J Am Coll Cardiol 38 (2001) 1357-1365
2. Abdelhadi R.H., Gurm H.S., Van Wagoner D.R., and Chung M.K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
3. Acikel S., Bozbas H., Gultekin B., Aydinalp A., Saritas B., Bal U., et al. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int J Cardiol (2007) [Electronic publication ahead of print]
4. Adam O., Frost G., Custodis F., Sussman M.A., Schäfers H.J., Böhm M., et al. Role of Rac1 GTPase activation in atrial fibrillation. Am Coll Cardiol 50 (2007) 359-367
5. Adams D.H., Heyer E.J., and Simon A.E. Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit Care Med 28 (2000) 309-311
6. Afzal A.R., Mandal K., Nyamweya S., Foteinos G., Poloniecki J., Camm A., et al. Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels. Cardiology 110 (2007) 45-52
7. Ago T., Kitazono T., Ooboshi H., Iyama T., Han Y.H., and Takada J. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109 (2004) 227-233
8. Akira S. IL-6-regulated transcription factors. Int J Biochem Cell Biol 29 (1997) 1401-1418
9. Alberte C., and Zipes D.P. Use of nonantiarrhythmic drugs for prevention of sudden cardiac death. J Cardiovasc Electrophysiol 14 9 Suppl (2003) S87-S95
10. Alexander-North L.S., North J.A., Kiminyo K.P., Buettner G.R., and Spector A.A. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 35 (1994) 1773-1785
11. Allessie M.A., Boyden P.A., Camm A.J., Kléber A.G., Lab M.J., Legato M.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
12. Allessie M., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54 (2002) 230-246
13. Almassi G.H., Schowalter T., Nicolosi A.C., Aggarwal A., Moritz T.E., Henderson W.G., et al. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg 226 (1997) 501-511
14. Amar D., Goenka A., Zhang H., Park B., and Thaler H.T. Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann Thorac Surg 82 (2006) 1057-1061
15. Ambros J.T., Herrero-Fresneda I., Borau O.G., and Boira J.M. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 20 (2007) 219-229
16. Ambrosio G., and Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138 2 Pt 2 (1999) S69-S75
17. Anderson K.E., Du X.J., Sinclair A.J., Woodcock E.A., and Dart A.M. Dietary fish oil prevents reperfusion Ins(1,4,5)P3 release in rat heart: possible antiarrhythmic mechanism. Am J Physiol 271 4 Pt 2 (1996) H1483-H1490
18. Andrews M., and Nelson B.P. Atrial fibrillation. Mount Sinai J Med 73 (2006) 482-492
19. Andrews T., Reimold S., Berlin J., and Antman E. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 84 Suppl (1991) III236-III244
20. Arab K., Rossary A., Flourié F., Tourneur Y., and Steghens J.- P. Docosahexaenoicacid enhances the antioxidant response of human fibroblasts by upregulating γ-glutamyl-cysteinyl ligase and glutathione reductase. Br J Nutr 95 (2006) 18-26
21. Arumanayagam M., Chan S., Tong S., and Sanderson J.E. Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomized controlled trial. J Cardiovasc Pharmacol 37 (2001) 48-54
22. Ataka K., Chen D., McCully J., Levitsky S., and Feinberg H. Magnesium cardioplegia prevents accumulation of cytosolic calcium in the ischemic myocardium. J Mol Cell Cardiol 25 (1993) 1387-1390
23. Attia D.M., Verhagen A.M., Stroes E.S., van Faassen E.E., Gröne H.J., De Kimpe S.J., et al. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol 12 (2001) 2585-2593
24. Auer J., Berent R., Weber T., Ng C.K., Lassnig E., Lamm G., et al. Antiarrhythmic therapy on prevention of postoperative atrial fibrillation in patients after heart surgery. Curr Med Chem Cardiovasc Hematol Agents 2 (2004) 29-34
25. Auer J., Weber T., Berent R., Ng C.K., Lamm G., and Eber B. Risk factors of postoperative atrial fibrillation after cardiac surgery. J Card Surg 20 (2005) 425-431
26. Augoustides J.G., Szeto W., Ochroch E.A., Cowie D., Weiner J., Gambone A.J., et al. Atrial fibrillation after aortic arch repair requiring deep hypothermic circulatory arrest: incidence, clinical outcome, and clinical predictors. J Cardiothorac Vasc Anesth 21 (2007) 388-392
27. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
28. Baker W.L., and White C.M. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 41 (2007) 587-598
29. Baker W.L., and White C.M. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation. Conn Med 71 (2007) 205-209
30. Baker W.L., White C.M., Kluger J., Denowitz A., Konecny C.P., and Coleman C.I. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm 4 (2007) 461-468
31. Banach M., Rysz J., Drozdz J.A., Okonski P., Misztal M., Barylski M., et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. Circ J 70 (2006) 438-441
32. Barth A.S., Merk S., Arnoldi E., Zwermann L., Kloos P., Gebauer M., et al. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res 96 (2005) 1022-1029
33. Béard T., Carrié D., Boyer M.J., Boudjemaa B., Ferrières J., Delay M., et al. Production of oxygen free radicals in myocardial infarction treated by thrombolysis. Analysis of glutathione peroxidase, superoxide dismutase and malondialdehyde. Arch Mal Coeur Vaiss 87 (1994) 1289-1296
34. Becker L.B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61 (2004) 461-470
35. Becker L.C., and Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30 (1987) 23-44
36. Benzie I.F. Evolution of dietary antioxidants. Comp Biochem Physiol A Mol Integr Physiol 136 (2003) 113-126
37. Biscione F., Pignalberi C., Totteri A., Messina F., and Altamura G. Cardiovascular effects of omega-3 free fatty acids. Curr Vasc Pharmacol 5 (2007) 163-172
38. Boldt A., Wetzel U., Weigl J., Garbade J., Lauschke J., Hindricks G., et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 42 (2003) 1785-1792
39. Bolli R. The late phase of preconditioning. Circ Res 87 (2000) 972-983
40. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33 (2001) 1897-1918
41. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
42. Bordoni A., Astolfi A., Morandi L., Pession A., Danesi F., Di Nunzio M., et al. n-3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure. FEBS Lett 581 (2007) 923-929
43. Boriani G., Valzania C., Diemberger I., Biffi M., Martignani C., Bertini M., et al. Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death. Expert Opin Investig Drugs 16 (2007) 605-623
44. Borzak S., Tisdale J.E., Amin N.B., Goldberg A.D., Frank D., Padhi I.D., et al. Atrial fibrillation after artery bypass surgery: does the arrhythmia or the characteristics of the patients prolong hospital stay?. Chest 113 (1998) 1489-1491
45. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59 (2000) 13-23
46. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword?. J Clin Invest 76 (1985) 1713-1719
47. Breslow J.L. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83 6 Suppl (2006) 1477S-1482S
48. Brouwer I.A., Geelen A., and Katan M.B. n-3 fatty acids, cardiac arrhythmia and fatal coronary heart disease. Prog Lipid Res 45 (2006) 357-367
49. Brundel B.J., Shiroshita-Takeshita A., Qi X., Yeh Y.H., Chartier D., van Gelder I.C., et al. Induction of heat shock response protects the heart against atrial fibrillation. Circ Res 99 (2006) 1394-1402
50. Budeus M., Feindt P., Gams E., Wieneke H., Sack S., Erbel R., et al. Beta-blocker prophylaxis for atrial fibrillation after coronary artery bypass grafting in patients with sympathovagal imbalance. Ann Thorac Surg 84 (2007) 61-66
51. Burgess D.C., Kilborn M.J., and Keech A.C. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 23 (2006) 2846-2857
52. Butler J., Chong J.L., Rocker G.M., Pillai R., and Westaby S. Atrial fibrillation after coronary artery bypass grafting: a comparison of cardioplegia versus intermittent aortic cross-clamping. Eur J Cardiothorac Surg 7 (1993) 23-25
53. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
54. Calder P.C. Omega 3 polyunsaturated fatty acids, inflammation and immunity. World Rev Nutr Diet 88 (2001) 109-116
55. Calò L., Bianconi L., Colivicchi F., Lamberte F., Loricchio M.L., de Ruvo E., et al. n-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 45 (2005) 1723-1728
56. Carnes C.A., Cheng M.K., Nakayama T., Nakayama H., Baliga R.S., Piao S., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89 (2001) E32-E38
57. Caro A.A., and Cederbaum A.I. Role of cytochrome P450 in phospholipase A2- and arachidonic acid-mediated cytotoxicity. Free Radic Biol Med 40 (2006) 364-375
58. Carr A.C., Zhu B.Z., and Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res 87 (2000) 349-354
59. Cave A.C., Grieve D.J., Johar S., Zhang M., and Shah A.M. NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Phil Trans Royal Soc 360 (2005) 2327-2334
60. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29 (2000) 323-333
61. Chello M., Patti G., Candura D., Mastrobuoni S., Di Sciascio G., Agrò F., et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 34 (2006) 660-667
62. Chen Y.J., Chen S.A., Chen Y.C., Yeh H.I., Chan P., Chang M.S., et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation 104 (2001) 2849-2854
63. Chen Y.C., Chen S.A., Chen Y.J., Chang M.S., Chan P., and Lin C.I. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J AmColl Cardiol 39 (2002) 366-372
64. Christensen J.H. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability. Dan Med Bull 50 (2003) 347-367
65. Christensen J.H., Riahi S., Schmidt E.B., Mølgaard H., Kirstein Pedersen A., Heath F., et al. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace 7 (2005) 338-344
66. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., et al. C-reactive protein elevation in subjects with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
67. Chung C.Y., Bien H., and Entcheva E. The role of cardiac tissue alignment in modulating electrical function. J Cardiovasc Electrophysiol 18 (2007) 1323-1329
68. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70 (2006) 231-239
69. Coleman C.I., Perkerson K.A., Gillespie E.L., Kluger J., Gallagher R., Horowitz S., et al. Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 38 (2004) 2012-2016
70. Coleman C.I., Makanji S., Kluger J., and White C.M. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Pharmacother 41 (2007) 433-437
71. Connolly S.J., Cybulsky I., Lamy A., Roberts R.S., O'brien B., Carroll S., et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 145 (2003) 226-232
72. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 94 (2004) 508-510
73. Cook-Mills J.M., Johnson J.D., Deem T.L., Ochi A., Wang L., and Zheng Y. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem J 378 Pt 2 (2004) 539-547
74. Creswell L.L., Schuessler R.B., Rosenbloom M., and Cox J.L. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 56 (1993) 539-549
75. Creswell L.L., Alexander J.C., Ferguson T.B., Lisbon A., and Fleisher L.A. American College of Chest Physicians. Intraoperative interventions: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 128 (2005) 28S-35S
76. Crystal E., Connolly S.J., Sleik K., Ginger T.J., and Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 106 (2002) 75-80
77. da Cunha D.N., Hamlin R.L., Billman G.E., and Carnes C.A. n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling. Br J Pharmacol 150 (2007) 281-285
78. Daoud E., Strickberger S., Man K., Goyal R., Deeb G., Bolling S., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
79. Dargie H.J. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
80. de Bakker J.M., Ho S.Y., and Hocini M. Basic and clinical electrophysiology of pulmonary vein ectopy. Cardiovasc Res 54 (2002) 287-294
81. Dell'Orfano J.T., Luck J.C., Wolbrette D.L., Patel H., and Naccarelli G.V. Drugs for conversion of atrial fibrillation. Am Fam Phys 58 (1998) 471-480
82. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
83. Dernellis J., and Panaretou M. Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillation. Acta Cardiol 61 (2006) 507-511
84. Dernellis J., and Panaretou M. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 97 (2006) 245-248
85. De Vecchi E., Pala M.G., Di Credico G., Agape V., Paolini G., and Bonini P.A. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 79 (1998) 242-247
86. Dimmer C., Tavernier R., Gjorgov N., Van Nooten G., Clement D.L., and Jordaens L. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 82 (1998) 22-25
87. Dogan S.M., Buyukates M., Kandemir O., Aydin M., Gursurer M., Acikgoz S., et al. Predictors of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 18 (2007) 327-331
88. Dudley Jr. S.C., Hoch N.E., McCann L.A., Honeycutt C., Diamandopoulus L., Fukai T., et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112 (2005) 1266-1273
89. Dunning J., Botha P., and Amanullah M. Prophylactic Amiodarone effectively prevents post-operative atrial fibrillation. Interact Cardiovasc Thorac Surg 3 (2004) 510-515
90. Eagle K.A., Guyton R.A., Davidoff R., Edwards F.H., Ewy G.A., Gardner T.J., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery); American College of Cardiology; American Heart Association. Circulation 110 (2004) 340-437
91. Ekim H., Kutay V., Hazar A., Akbayrak H., Başel H., and Tuncer M. Effects of posterior pericardiotomy on the incidence of pericardial effusion and atrial fibrillation after coronary revascularization. Med Sci Monit 12 (2006) CR431-CR434
92. El-Adawi H., Deng L., Tramontano A., Smith S., Mascareno E., Ganguly K., et al. The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovasc Res 57 (2003) 129-138
93. Elahi M., Hadjinikolaou L., and Galiñanes M. Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation 108 (2003) 207-212
94. Emara A.M., El Kelany R.S., and Moustafa K.A. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats. Hum Exp Toxicol 25 (2006) 375-385
95. Everett T.H., and Olgin J.E. Heart Rhythm. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 4 (2007) S24-S27
96. Everett T.H., Li H., Mangrum J.M., McRury I.D., Mitchell M.A., Redick J.A., et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation 102 (2000) 1454-1460
97. Fam S.S., Murphey L.J., Terry E.S., Zackert W.E., Chen Y., Gao L., et al. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 277 (2002) 36076-36084
98. 2+ channel. J Physiol 500 Pt 3 (1997) 551-556
99. Fenelon G., Shepard R.K., and Stambler B.S. Focal origin of atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Electrophysiol 14 (2003) 1093-1102
100. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138 (2003) 532-543
101. Feringa H.H., Karagiannis S., Vidakovic R., Noordzij P.G., Brugts J.J., Schouten O., et al. Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Am J Cardiol 100 (2007) 1479-1484
102. 2+ current in adult cardiac myocytes. Cardiovasc Res 54 (2002) 601-610
103. Fontes M.L., Mathew J.P., Rinder H.M., Zelterman D., Smith B.R., and Rinder C.S. Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation. Multicenter Study of Perioperative Ischemia (McSPI). Res Group Anesth Analg 101 (2005) 17-23
104. Frank S.M., Higgins M.S., Breslow M.J., Fleisher L.A., Gorman R.B., Sitzmann J.V., et al. The catecholamine, cortisol, and hemodynamic responses to mild perioperative hypothermia. A randomized clinical trial. Anesthesiology 82 (1995) 83-93
105. Frost L., and Vestergaard P. n-3 fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 81 (2005) 50-54
106. Fruehauf J.P., and Meyskens F.L. Reactive oxygen species: a breath of life or death?. Clin Cancer Res 13 (2007) 789-794
107. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
108. Gaborit N., Steenman M., Lamirault G., Le Meur N., Le Bouter S., Lande G., et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112 (2005) 471-481
109. Gao L., Wang J., Sekhar K.R., Yin H., Yared N.F., Schneider S.N., et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 282 (2007) 2529-2537
110. Gaudino M., Andreotti F., Zamparelli R., Di Castelnuovo A., Nasso G., Burzotta F., et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 Suppl 1 (2003) II195-II199
111. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., and Kok F.J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20 (2002) 1493-1499
112. Gille L., Staniek K., and Nohl H. Effects of tocopheryl quinone on the heart: model experiments with xanthine oxidase, heart mitochondria, and isolated perfused rat hearts. Free Radic Biol Med 30 (2001) 865-876
113. Gillespie E.L., White M., Kluger J., Sahni J., Gallagher R., and Coleman C. A hospital perspective on the cost-effectiveness of b-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Therap 27 (2005) 1963-1969
114. Gillespie E.L., White C.M., Kluger J., Rancourt J.A., Gallagher R., and Coleman C.I. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 26 (2006) 499-504
115. Goette A., Staack T., Röcken C., Arndt M., Geller J.C., Huth C., et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2000) 1669-1677
116. Goette A., Lendeckel U., and Klein H.U. Signal transduction systems and atrial fibrillation. Cardiovasc Res 54 (2002) 247-258
117. Gong Y., Xie F., Stein K.M., Garfinkel A., Culianu C.A., Lerman B.B., et al. Mechanism underlying initiation of paroxysmal atrial flutter/atrial fibrillation by ectopic foci: a simulation study. Circulation 115 (2007) 2094-2102
118. Goodfellow J., Bellamy M.F., Ramsey M.W., Jones C.J., and Lewis M.J. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35 (2000) 265-270
119. Grabellus F., Levkau B., Sokoll A., Welp H., Schmid C., Deng M.C., et al. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 53 (2002) 124-130
120. Guarnieri Th., Nolan S., Gottlieb S., Dudek A., and Lowry D. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. J Am Coll Cardiol 34 (1999) 343-347
121. Haghjoo M., Saravi M., Hashemi M.J., Hosseini S., Givtaj N., Ghafarinejad M.H., et al. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm 4 (2007) 1170-1174
122. Haïssaguerre M., Jaïs P., Shah D.C., Takahashi A., Hocini M., Quiniou G., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
123. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion - A target for cardioprotection. Cardiovasc Res 61 (2004) 372-385
124. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34 Pt 2 (2006) 232-237
125. Halestrap A.P., Clarke S.J., and Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767 (2007) 1007-1731
126. Harris W.S., Rambjør G.S., Windsor S.L., and Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr 65 (1997) 459-464
127. Harris W.S., and Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
128. Harris W.S. Extending the cardiovascular benefits of omega-3 fatty acids. Curr Atheroscler Rep 7 (2005) 375-380
129. Hashimoto T., Fukatani M., Mori M., and Hashiba K. Effects of standing on the induction of paroxysmal supraventricular tachycardia. J Am Coll Cardiol 17 (1991) 690-695
130. Hattori R., Maulik N., Otani H., Zhu L., Cordis G., Engelman R.M., et al. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 33 (2001) 1929-1936
131. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A., Stakos D., Floros D., Papanas N., et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 97 (2006) 659-661
132. Heller R., Werner-Felmayer G., and Werner E.R. Alpha-Tocopherol and endothelial nitric oxide synthesis. Ann N Y Acad Sci 1031 (2004) 74-85
133. Heller R., Werner-Felmayer G., and Werner E.R. Antioxidants and endothelial nitric oxide synthesis. Eur J Clin Pharmacol 62 Suppl. 13 (2006) 21-28
134. Hess M.L., and Manson N.H. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 16 (1984) 969-985
135. Heymes C., Bendall J.K., Ratajczak P., Cave A.C., Samuel J.L., Hasenfuss G., et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41 (2003) 2164-2171
136. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95 (2004) 187-195
137. Hilfiker-Kleiner D., Hilfiker A., and Drexler H. Many good reasons to have STAT3 in the heart. Pharmacol Ther 107 (2005) 131-137
138. Hilleman D.E., Hunter C.B., Mohiuddin S.M., and Maciejewski S. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs 5 (2005) 361-369
139. Hkala T., and Hedman A. Predicting the risk of atrial fibrillation after coronary artery bypass surgery. Scand Cardiovasc J 6 (2003) 309-315
140. Hogue C.h., and Hyder M. Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg 69 (2000) 300-306
141. Hogue Jr. C.W., Palin C.A., Kailasam R., Lawton J.S., Nassief A., Dávila-Román V.G., et al. C-reactive protein levels and atrial fibrillation after cardiac surgery in women. Ann Thorac Surg 82 (2006) 97-102
142. Hohnloser S.H. Can we predict atrial fibrillation after coronary surgery and why should we?. Eur Heart J 19 (1991) 684-685
143. Horiba M., Kadomatsu K., Yasui K., Lee J.K., Takenaka H., Sumida A., et al. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114 (2006) 1713-1720
144. Hornstra G. Influence of dietary fat type on arterial thrombosis tendency. J Nutr Health Aging 5 (2001) 160-166
145. Hosokawa K., Nakajima Y., Umenai T., Ueno H., Taniguchi S., Matsukawa T., et al. Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery. Br J Anaesth 98 (2007) 575-580
146. Huang H.Y., and Appel L.J. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 133 (2003) 3137-3140
147. Hulbert A.J., Turner N., Storlien L.H., and Else P.L. Dietary fats and membrane function: implications for metabolism and disease. Biol Rev Camb Philos Soc 80 (2005) 155-169
148. Humphries K.H., Lee M., Sheldon R., Ramanathan K., Dorian P., Green M., et al. Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J 154 (2007) 908-913
149. Iravanian S., and Dudley Jr. S.C. Oxidative stress and the pathogenesis of atrial fibrillation. Curr Cardiol Rev 2 (2006) 247-254
150. Iraz M., Erdogan H., Ozyurt B., Ozugurlu F., Ozgocmen S., and Fadillioglu E. Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats. Ann Clin Lab Sci 35 (2005) 169-173
151. Ishida K., Kimura F., Imamaki M., Ishida A., Shimura H., Kohno H., et al. Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 29 (2006) 501-505
152. Ito M., Adachi T., Pimentel D.R., Ido Y., and Colucci W.S. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism. Circulation 110 (2004) 412-418
153. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13 (1999) 76-86
154. Iwase H., Robin E., Guzy R.D., Mungai P.T., Vanden Hoek T.L., Chandel N.S., et al. Nitric oxide during ischemia attenuates oxidant stress and cell death during ischemia and reperfusion in cardiomyocytes. Free Radic Biol Med 43 (2007) 590-599
155. Jahangiri A., Leifert W.R., Patten G.S., and McMurchie E.J. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem 206 (2000) 33-41
156. Jahangiri A., Leifert W.R., Kind K.L., and McMurchie E.J. Dietary fish oil alters cardiomyocyte Ca(2+) dynamics and antioxidant status. Free Radic Biol Med 40 (2006) 1592-1602
157. Jaïs P., Haïssaguerre M., Shah D.C., Chouairi S., and Clémenty J. Regional disparities of endocardial atrial activation in paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 19 (1996) 1998-2003
158. Jaïs P., Weerasooriya R., Shah D.C., Hocini M., Macle L., Choi K.J., et al. Ablation therapy for atrial fibrillation (AF): past, present and future. Cardiovasc Res 54 (2002) 337-346
159. Jennings R.B., and Reimer K.A. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 68 2 Pt 2 (1983) 125-136
160. Ji B., Liu J., Liu M., Feng Z., Wang G., Lu F., et al. Effect of cold blood cardioplegia enriched with potassium-magnesium aspartate during coronary artery bypass grafting. J Cardiovasc Surg (Torino) 47 (2006) 671-675
161. Jouven X., Charles M.A., Desnos M., and Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104 (2001) 756-776
162. Kalman J.M., Munawar M., Howes L.G., Louis W.J., Buxton B.F., Gutteridge G., et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 60 (1995) 1709-1715
163. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
164. Karthik S., Grayson A.D., Oo A.Y., and Fabri B.M. A survey of current myocardial protection practices during coronary artery bypass grafting. Ann R Coll Surg Engl 86 (2004) 413-415
165. Katritsis D.G., Panagiotakos D.B., Karvouni E., Giazitzoglou E., Korovesis S., Paxinos G., et al. Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. Am J Cardiol 92 (2003) 1116-1119
166. Kawano S., Kubota T., Monden Y., Tsutsumi T., Inoue T., Kawamura N., et al. Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291 (2006) H1337-H1344
167. Kecskeméti V., Kelemen K., Solti F., and Szabó Z. Physiological and pharmacological analysis of transmembrane action potentials of human atrial fibers. Adv Myocardiol 6 (1985) 37-47
168. Kernis S.J., Nkomo V.T., Messika-Zeitoun D., Gersh B.J., Sundt T.M., Ballman K.V., et al. Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm: incidence, outcome, and determinants. Circulation 110 (2004) 2320-2325
169. Kilgore K.S., and Lucchesi B.R. Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. Clin Biochem 26 (1993) 359-370
170. Killig F., and Stark G. Photodynamic activation of ion transport through lipid membranes and its correlation with an increased dielectric constant of the membrane. Biochim Biophys Acta 1564 (2002) 207-213
171. Kim F.J., Moore E.E., Moore F.A., Read R.A., and Burch J.M. Trauma surgeons can render definitive surgical care for major thoracic injuries. J Trauma 36 (1994) 871-875
172. Kim Y.H., Lim D.S., Lee J.H., Shim W.J., Ro Y.M., Park G.H., et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35 (2003) 336-349
173. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97 (2005) 629-636
174. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: part 1. Circulation 104 (2001) 2981-2989
175. Kloner R.A., and Jennings R.B. Consequences brief of ischemia: Stunning, preconditioning, and their clinical implications: part 2. Circulation 104 (2001) 3158-3167
176. Knapp H.R. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65 5 Suppl (1997) 1687S-1698S
177. Kojodjojo P., Peters N.S., Davies D.W., and Kanagaratnam P. Characterization of the electroanatomical substrate in human atrial fibrillation: the relationship between changes in atrial volume, refractoriness, wavefront propagation velocities, and AF burden. J Cardiovasc Electrophysiol 18 (2007) 269-275
178. Korantzopoulos P., Kolettis T., Siogas K., and Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9 (2003) RA225-RA229
179. Korantzopoulos P., Kolettis T.M., Kountouris E., Dimitroula V., Karanikis P., Pappa E., et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 (2005) 321-326
180. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
181. Koutlas T.C., Elbeery J.R., Williams J.M., Moran J.F., Francalancia N.A., and Chitwood Jr. W.R. Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery. Ann Thorac Surg 69 (2000) 1042-1047
182. Kubota T., Miyagishima M., Alvarez R.J., Kormos R., Rosenblum W.D., Demetris A.J., et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 19 (2000) 819-824
183. Kühn P., Oberthaler G., and Oswald J. Anti-arrhythmia effectiveness of potassium-magnesium-aspartate infusion. Wien Med Wochenschr 141 (1991) 64-65
184. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4 (2004) 181-189
185. Lamm G., Auer J., Weber T., Berent R., Ng C., and Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 20 (2006) 51-56
186. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
187. Leaf A., Xiao Y.F., Kang J.X., and Billman G.E. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J Membr Biol 206 (2005) 129-139
188. Lee J.M., Li J., Johnson D.A., Stein T.D., Kraft A.D., Calkins M.J., et al. Nrf2, a multi-organ protector?. FASEB J 19 (2005) 1061-1066
189. Lefer A.M., and Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32 (1996) 743-751
190. Leifert W.R., Jahangiri A., and McMurchie E.J. Antiarrhythmic fatty acids and antioxidants in animal and cell studies. J Nutr Biochem 10 (1999) 252-267
191. Leifert W.R., McMurchie E.J., and Saint D.A. Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids. J Physiol 520 Pt 3 (1999) 671-679
192. Leifert W.R., Jahangiri A., and McMurchie E.J. Membrane fluidity changes are associated with the antiarrhythmic effects of docosahexaenoic acid in adult rat cardiomyocytes. J Nutr Biochem 11 (2000) 38-44
193. Leonardi F., Attorri L., Benedetto R.D., Biase A.D., Sanchez M., Tregno F., et al. Docosahexaenoic acid supplementation induces dose and time dependent oxidative changes in C6 glioma cells. Free Radic Res 41 (2007) 748-756
194. Levine M., Rumsey S.C., Daruwala R., Park J.B., and Wang Y. Criteria and recommendations for vitamin C intake. JAMA 281 (1999) 1415-1423
195. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 378 Pt 2 (2004) 373-382
196. Levy F., Garayalde E., Quere J.P., Ianetta-Peltier M., Peltier M., and Tribouilloy C. Prognostic value of preoperative atrial fibrillation in patients with aortic stenosis and low ejection fraction having aortic valve replacement. Am J Cardiol 98 (2006) 809-811
197. Li J.M., and Shah A.M. Endothelial cell superoxide generation: Regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1014-R1030
198. Li G.C., Vasquez J.A., Gallagher K.P., and Lucchesi B.R. Myocardial protection with preconditioning. Circulation 82 (1990) 609-619
199. Li D., Melnyk P., Feng J., Wang Z., Petrecca K., Shrier A., et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101 (2000) 2631-2638
200. Liakopoulos O.J., Schmitto J.D., Kazmaier S., Bräuer A., Quintel M., Schoendube F.A., et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 84 (2007) 110-118
201. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S., et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart study. Circulation 110 (2004) 1042-1046
202. Lo B., Fijnheer R., Nierich A.P., Bruins P., and Kalkman C.J. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 79 (2006) 1530-1535
203. Maekawa N., Wada H., Kanda T., Niwa T., Yamada Y., Saito K., et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 39 (2002) 1229-1235
204. Magee M.J., Herbert M.A., Dewey T.M., Edgerton J.R., Ryan W.H., Prince S., et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg 83 (2007) 1707-1712
205. Maisel W.H., and Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91 (2003) 2D-8D
206. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073
207. Mandal K., Torsney E., Poloniecki J., Camm A.J., Xu Q., and Jahangiri M. Association of high intracellular, but not serum, heat shock protein 70 with postoperative atrial fibrillation. Ann Thorac Surg 79 (2005) 865-871
208. Manganas H., Lacasse Y., Bourgeois S., Perron J., Dagenais F., and Maltais F. Postoperative outcome after coronary artery bypass grafting in chronic obstructive pulmonary disease. Can Respir J 14 (2007) 19-24
209. Manning W.J., Leeman D.E., Gotch P.J., and Come P.C. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13 (1989) 617-623
210. Manning W.J., Silverman D.I., Katz S.E., Riley M.F., Come P.C., Doherty R.M., et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23 (1994) 1535-1540
211. Marín F., Pascual D.A., Roldán V., Arribas J.M., Ahumada M., Tornel P.L., et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97 (2006) 55-60
212. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
213. Mariscalco G., Lorusso R., Klersy C., Ferrarese S., Tozzi M., Vanoli D., et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 84 (2007) 1158-1164
214. Mathew J.P., Parks R., Savino J.S., Friedman A.S., Koch C., Mangano D.T., and Browner W.S. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. J Am Med Assoc 276 (1996) 300-306
215. Mathew J.P., Parks R., Savino J.S., Friedman A.S., Koch C., Mangano D.T., et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 276 (1996) 300-306
216. Mathew J.P., Fontes M.L., Tudor J.C., Ramsay J., Duke P., Mazer C.D., et al. A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc 291 (2004) 1720-1729
217. May P., Schniertshauer U., Gerhartz C., Horn F., and Heinrich P.C. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation. Acta Biochim Pol 50 (2003) 595-601
218. McMurchie E.J., Leifert W.R., and Head R.J. Antiarrhythmic properties of n-3 fatty acids in cardiomyocytes: a role for membrane fluidity?. In: Riemersma R.A., Armstrong R.A., Kelly R.W., and Wilson R. (Eds). Essential Fatty Acids and Eicosanoids (1999), AOCS Press, Champaign, IL, USA 284-289
219. Merla R., Daher I.N., Ye Y., Uretsky B.F., and Birnbaum Y. Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms. Am Heart J 154 (2007) 391-402
220. Merritt J.C., Niebauer M., Tarakji K., Hammer D., and Mills R.M. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol 92 (2003) 735-736
221. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
222. Mitchell L.B. Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery. Curr Opin Cardiol 22 (2007) 18-24
223. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol 100 (2005) 179-190
224. Morgan D.R., Dixon L.J., Hanratty C.G., El-Sherbeeny N., Hamilton P.B., McGrath L.T., et al. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 97 (2006) 547-551
225. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., and Siscovick D.S. Cardiovascular Health Study. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107 (2003) 1372-1377
226. Mozaffarian D., Psaty B.M., Rimm E.B., Lemaitre R.N., Burke G.L., Lyles M.F., et al. Fish intake and risk of incident atrial fibrillation. Circulation 110 (2004) 368-373
227. Mozaffarian D., Prineas R.J., Stein P.K., and Siscovick D.S. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. J Am Coll Cardiol 48 (2006) 478-484
228. Mueller X.M., Tevaearai H.T., Ruchat P., Stumpe F., and Von Segesser L.K. Did the introduction of a minimally invasive technique change the incidence of atrial fibrillation after single internal thoracic artery-left anterior descending artery grafting?. J Thorac Cardiovasc Surg 121 (2001) 683-688
229. Murdoch C.E., Zhang M., Cave A.C., and Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71 (2006) 208-215
230. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1236
231. Nair S.S., Leitch J., and Garg M.L. Suppression of inositol phosphate release by cardiac myocytes isolated from fish oil-fed pigs. Mol Cell Biochem 215 (2000) 57-64
232. Nakamura M.T., Cheon Y., Li Y., and Nara T.Y. Mechanisms of regulation of gene expression by fatty acids. Lipids 39 (2004) 1077-1083
233. Nakano Y., Niida S., Dote K., Takenaka S., Hirao H., Miura F., et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43 (2004) 818-825
234. Nälsén C., Vessby B., Berglund L., Uusitupa M., Hermansen K., Riccardi G., et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J Nutr 136 (2006) 1222-1228
235. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415 (2002) 219-226
236. Nattel S., Shiroshita-Takeshita A., Brundel B.J., and Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis 48 (2005) 9-28
237. Nattel S., Maguy A., Le Bouter S., and Yeh Y.H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87 (2007) 425-456
238. Neuman R.B., Bloom H.L., Shukrulla I., Darrow L.A., Kleinbaum D., Jones D.P., et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53 (2007) 1652-1657
239. Ohki R., Yamamoto K., Ueno S., Mano H., Misawa Y., Fuse K., et al. Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int J Cardiol 102 (2005) 233-238
240. Ohki-Kaneda R., Ohashi J., Yamamoto K., Ueno S., Ota J., Choi Y.L., et al. Cardiac function-related gene expression profiles in human atrial myocytes. Biochem Biophys Res Commun 320 (2004) 1328-1336
241. O'Keefe Jr. J.H., Abuissa H., Sastre A., Steinhaus D.M., and Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97 (2006) 1127-1130
242. O'Neill S.C., Perez M.R., Hammond K.E., Sheader E.A., and Negretti N. Direct and indirect modulation of rat cardiac sarcoplasmic reticulum function by n-3 polyunsaturated fatty acids. J Physiol 538 Pt 1 (2002) 179-184
243. Opie L.H. Role of calcium and other ions in reperfusion injury. Cardiovasc Drugs Ther 5 Suppl 2 (1991) 237-247
244. Osranek M., Fatema K., Qaddoura F., Al-Saileek A., Barnes M.E., Bailey K.R., et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 48 (2006) 779-786
245. Ozaydin M., Varol E., Aslan S.M., Kucuktepe Z., Dogan A., Ozturk M., et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 9 (2006) 1490-1493
246. Ozaydin M., Dogan A., Varol E., Kapan S., Tuzun N., Peker O., et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 107 (2007) 117-121
247. Pabla R., and Curtis M. Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro. Br J Pharmacol 150 (2007) 893-898
248. Pak H.N., Hwang C., Lim H.E., Kim J.W., Lee H.S., and Kim Y.H. Electroanatomic characteristics of atrial premature beats triggering atrial fibrillation in patients with persistent versus paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 17 (2006) 818-824
249. Park J.L., and Lucchesi B.R. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68 (1999) 1905-1912
250. Patti G., Chello M., Candura D., Pasceri V., D'Ambrosio A., Covino E., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation 114 (2006) 1455-1461
251. Pauly D.F., and Pepine C.J. Ischemic heart disease: metabolic approaches to management. Clin Cardiol 27 (2004) 439-441
252. Poliukhovich G.S., Vasil'eva L.P., Maslova G.T., Boboriko T.L., and Speranskiǐ S.D. Efficacy of various antioxidants in experimental ischemia and myocardial infarct in the rat. Vopr Med Khim 37 (1991) 54-56
253. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
254. Prasongsukarn K., Abel J.G., Jamieson W.R., Cheung A., Russell J.A., Walley K.R., et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 130 (2005) 93-98
255. Qin F., Shite J., and Liang C.S. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol 285 (2003) H822-H832
256. 2+ ATPase downregulation after myocardial infarction. Free Radic Biol Med 40 (2006) 1827-1842
257. Ramanna H., Hauer R.N., Wittkampf F.H., de Bakker J.M., Wever E.F., Elvan A., et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. Circulation 101 (2000) 995-1001
258. Rezkalla S.H., and Kloner R.A. Preconditioning in humans. Heart Fail Rev 12 (2007) 201-206
259. Rinne T., Mutschler E., Wimmer-Greinecker G., Moritz A., and Olbrich H.G. Vitamins C and E protect isolated cardiomyocytes against oxidative damage. Int J Cardiol 75 (2000) 275-281
260. Roberts W.C., and Yoon D.H. Massive calcific deposits in the epicardial coronary arteries in the absence of calcific deposits in the aortic valve cusps and in the mitral valve annulus. Am J Geriatr Cardiol 11 (2002) 127-129
261. Rodrigo R., Bächler J.P., Araya J., Prat H., and Passalacqua W. Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem 303 (2007) 73-81
262. Rodrigo R., Castillo R., Cereceda M., Asenjo R., Zamorano J., and Araya J. Non-hypoxic preconditioning of myocardium against postoperative atrial fibrillation: mechanism based on enhancement of the antioxidant defense system. Med Hypotheses 69 (2007) 1242-1248
263. Roldan V., Marin F., Martinez J.G., Garcia-Herola A., Sogorb F., and Lip G.Y. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation. Am J Cardiol 95 (2005) 881-882
264. Rossano J.W., Smith E.O., Fraser C.D., McKenzie E.D., Chang A.C., Hemingway A., et al. Adults undergoing cardiac surgery at a children's hospital: an analysis of perioperative morbidity. Ann Thorac Surg 83 (2007) 606-612
265. Rossary A., Arab K., and Steghens J.P. Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts. Biochem J 406 (2007) 77-83
266. Sacks F.M., and Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113 Suppl 9B (2002) 13S-24S
267. Saksena S., Hettrick D.A., Koehler J.L., Grammatico A., and Padeletti L. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J 154 (2007) 884-892
268. Sata N., Hamada N., Horinouchi T., Amitani S., Yamashita T., Moriyama Y., et al. C-Reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
269. Sawa Y., Ichikawa H., Kagisaki K., Ohata T., and Matsuda H. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J Thorac Cardiovasc Surg 116 (1998) 511-517
270. Scapellato F., Temporelli P.L., Corrà U., Eleuteri E., Bosimini E., and Giannuzzi P. Doppler-derived acceleration rate of right ventricular early filling reliably predicts mean right atrial pressure at baseline and after loading manipulations in patients with chronic heart failure. Ital Heart J 1 (2000) 275-281
271. Schäfler A.E., Kirmanoglou K., Balbach J., Pecher P., Hannekum A., and Schumacher B. The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Res Cardiol 97 (2002) 258-261
272. Scherer M., Therapidis P., Wittlinger T., Miskovic A., and Moritz A. Impact of left atrial size reduction and endocardial radiofrequency ablation on continuous atrial fibrillation in patients undergoing concomitant cardiac surgery: three-year results. J Heart Valve Dis 16 (2007) 126-131
273. Schwarze M.M., and Hawley R.G. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55 (1995) 2262-2265
274. +-ATPase by oxyradical generating systems. Mol Cell Biochem 147 (1995) 139-144
275. Shiroshita-Takeshita A., Schram G., Lavoie J., and Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 110 (2004) 2313-2319
276. Shiroshita-Takeshita A., Brundel B.J., and Nattel S. Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 13 (2005) 181-193
277. Shiroshita-Takeshita A., Brundel B.J., Lavoie J., and Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69 (2006) 865-875
278. Shite J., Qin F., Mao W., Kawai H., Stevens S.Y., and Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol 38 (2001) 1734-1740
279. Sitges M., Teijeira V.A., Scalise A., Vidal B., Tamborero D., Collvinent B., et al. Is there an anatomical substrate for idiopathic paroxysmal atrial fibrillation? A case-control echocardiographic study. Europace 9 (2007) 294-298
280. Smith C., Marlin S., Rothlein R., Toman C., and Anderson D.C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83 (1989) 2008-2017
281. Solaini G., and Harris D.A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390 Pt 2 (2005) 377-394
282. Solomon A.J., Greenberg M.D., Kilborn M.J., and Katz N.M. Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 142 (2001) 811-815
283. Stambler B.S., Fenelon G., Shepard R.K., Clemo H.F., and Guiraudon C.M. Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacinginduced heart failure. J Cardiovasc Electrophysiol 14 (2003) 499-507
284. Stanley T.O., Mackensen G.B., Grocott H.P., White W.D., Blumenthal J.A., Laskowitz D.T., et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 94 (2002) 290-295
285. Stark G. Functional consequences of oxidative membrane damage. J Membr Biol 205 (2005) 1-16
286. Steinberg J.S., Zelenkofske S., Wong S.C., Gelernt M., Sciacca R., and Menchavez E. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation 88 (1993) 2618-2622
287. St Rammos K., Koullias G.J., Hassan M.O., Argyrakis N.P., Voucharas C.G., Scarupa S.J., et al. Low preoperative HSP70 atrial myocardial levels correlate significantly with high incidence of postoperative atrial fibrillation after cardiac surgery. Cardiovasc Surg 10 (2002) 228-232
288. Taffet G.E., Pham T.T., Bick D.L., Entman M.L., Pownall H.J., and Bick R.J. The calcium uptake of the rat heart sarcoplasmic reticulum is altered by dietary lipid. J Membr Biol 131 (1993) 35-42
289. Takahashi Y., Hocini M., O'Neill M.D., Sanders P., Rotter M., Rostock T., et al. Sites of focal atrial activity characterized by endocardial mapping during atrial fibrillation. J Am Coll Cardiol 47 (2006) 2005-2012
290. Thamilarasan M., and Klein A.L. Factors relating to left atrial enlargement in atrial fibrillation: chicken or the egg hypothesis. Am Heart J 137 (1999) 381-383
291. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361 9356 (2003) 477-485
292. Tisdale J.E., Borzak S., Sabbah H.N., Shimoyama H., and Goldstein S. Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure. J Card Fail 12 (2006) 747-751
293. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., and Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
294. Tselentakis E.V., Woodford E., Chandy J., Gaudette G.R., and Saltman A.E. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res 135 (2006) 68-75
295. Tveit A., Grundtvig M., Gundersen T., Vanberg P., Semb A.G., Holt E., et al. Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 93 (2004) 780-782
296. Ucar H.I., Tok M., Atalar E., Dogan O.F., Oc M., Farsak B., et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 10 (2007) E131-E135
297. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
298. Valen G., Yan Z.Q., and Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38 (2001) 307-314
299. Valen G., Owall A., Takeshima S., Goiny M., Ungerstedt U., and Vaage J. Metabolic changes induced by ischemia and cardioplegia: a study employing cardiac microdialysis in pigs. Eur J Cardiothorac Surg 25 (2004) 69-75
300. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39 (2007) 44-84
301. Valtola A., Kokki H., Gergov M., Ojanperä I., Ranta V.P., and Hakala T. Does coronary artery bypass surgery affect metoprolol bioavailability. Eur J Clin Pharmacol 63 (2007) 471-478
302. Van Belleghem Y., Caes F., Maene L., Van Overbeke H., Moerman A., Van Nooten G., et al. Off-pump coronary surgery: surgical strategy for the high-risk patient. Cardiovasc Surg 11 (2003) 75-79
303. Van Belleghem Y., Caes F., Maene L., Van Overbeke H., Moerman A., Van Nooten G., et al. Off-pump coronary surgery: surgical strategy for the high-risk patient. Cardiovasc Surg 11 (2003) 75-79
304. van Ginkel G., and Sevanian A. Lipid peroxidation-induced membrane structural alterations. Methods Enzymol 233 (1994) 273-288
305. van Haaften R.I., Haenen G.R., van Bladeren P.J., Bogaards J.J., Evelo C.T., and Bast A. Inhibition of various glutathione S-transferase isoenzymes by RRR-alpha-tocopherol. Toxicol In Vitro 17 (2003) 245-251
306. Van Wagoner D.R. Molecular basis of atrial fibrillation: a dream or a reality?. J Cardiovasc Electrophysiol 14 (2003) 667-669
307. Van Wagoner D.R. Recent insights into the pathophysiology of atrial fibrillation. Semin Thorac Cardiovasc Surg 19 (2007) 9-15
308. Vaporciyan A.A., Correa A.M., Rice D.C., Roth J.A., Smythe W.R., Swisher S.G., et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127 (2004) 779-786
309. Verhaar M.C., Westerweel P.E., van Zonneveld A.J., and Rabelink T.J. Free radical production by dysfunctional eNOS Review. Heart 90 (2004) 494-495
310. Verkerk A.O., van Ginneken A.C., Berecki G., den Ruijter H.M., Schumacher C.A., Veldkamp M.W., et al. Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials. Cardiovasc Res 70 (2006) 509-520
311. Vidaillet H., Granada J.F., Chyou P.H., Maassen K., Ortiz M., Pulido J.N., et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 113 (2002) 365-370
312. Villa E., Messina A., Cirillo M., and Troise G. Size matters in atrial fibrillation surgery. Eur J Cardiothorac Surg 32 (2007) 398-399
313. Villareal R.P., Hariharan R., Liu B.C., Kar B., Lee V.V., Elayda M., et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 43 (2004) 742-748
314. Vinten-Johansen J., Zhao Z.Q., Jiang R., Zatta A.J., and Dobson G.P. Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol (2007) [Electronic publication ahead of print]
315. 2+ channel function in the absence of apoptosis in ventricular myocytes. Circ Res 100 (2007) 1036-1044
316. Vitadello M., Ausma J., Borgers M., Gambino A., Casarotto D.C., and Gorza L. Increased myocardial GRP94 amounts during sustained atrial fibrillation: a protective response?. Circulation 103 (2001) 2201-2206
317. von Schacky C. The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 5 (2003) 139-145
318. von Schacky C. Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10 (2007) 129-135
319. von Schacky C., and Harris W.S. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73 (2007) 310-315
320. Wan S., and Yim A.P. Cytokines in myocardial injury: impact on cardiac surgical approach. Eur J Cardiothorac Surg 16 Suppl 1 (1999) S107-S111
321. Wang X., and Quinn P.J. The location and function of vitamin E in membranes (review). Mol Membr Biol 17 (2000) 143-156
322. Wang T.J., Larson M.G., Levy D., Vasan R.S., Leip E.P., Wolf P.A., et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation, 107 (2003) 2920-2925
323. Wang M., Tsai B.M., Crisostomo P.R., and Meldrum D.R. Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation 114 (2006) I282-I289
324. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
325. Wassmann S., Laufs U., Bäumer A.T., Müller K., Konkol C., Sauer H., et al. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 59 (2001) 646-654
326. Watanabe E., Arakawa T., Uchiyama T., Kodama I., and Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 108 (2006) 346-353
327. Wazni O.M., Martin D.O., Marrouche N.F., Latif A.A., Ziada K., Shaaraoui M., et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 110 (2004) 124-127
328. Weisfeldt M.L., Zweier J., Ambrosio G., Becker L.C., and Flaherty J.T. Evidence that free radicals result in reperfusion injury in heart muscle. Basic Life Sci 49 (1988) 911-919
329. Wijffels M.C., Kirchhof C.J., Dorland R., Power J., and Allessie M.A. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96 (1997) 3710-3720
330. Wijffels M.C., Kirchoff C.J., Dorland R., and Allessie M.A. Arial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
331. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991) 983-988
332. Wong S.C., Fukuchi M., Melnyk P., Rodger I., and Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98 (1998) 100-103
333. Xiao Y.F., Sigg D.C., and Leaf A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J Membr Biol 206 (2005) 141-154
334. Yang Q., Liu Y.C., Zou W., Yim A.P., and He G.W. Protective effect of magnesium on the endothelial function mediated by endothelium-derived hyperpolarizing factor in coronary arteries during cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg 124 (2002) 361-370
335. Yang X., Yuan J., Sun J., Wang H., Liang H., Bai Y., et al. Association between heat-shock protein 70 gene polymorphisms and DNA damage in peripheral blood lymphocytes among coke-oven workers. Mutat Res (2007, Sep 29) [Electronic publication ahead of print]
336. Yared J.P., Bakri M.H., Erzurum S.C., Moravec C.S., Laskowski D.M., Van Wagoner D., et al. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. J Cardiothorac Vasc Anesth 21 (2007) 68-75
337. Yasunari K., Maeda K., Nakamura M., Watanabe T., Yoshikawa J., and Asada A. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 116 (2004) 460-465
338. Yellon D.M., and Baxter G.F. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?. Heart 83 (2000) 381-387
339. Yousif H., Davies G., and Oakley C.M. Peri-operative supraventricular arrhythmias in coronary bypass surgery. Int J Cardiol 26 (1990) 313-318
340. Zaman A.G., Archbold R.A., Helft G., Paul E.A., Curzen N.P., and Mills P.G. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 101 (2000) 1403-1408
341. Zangrillo A., Landoni G., Sparicio D., Benussi S., Aletti G., Pappalardo F., et al. Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 18 (2004) 704-708
342. Zimmer J., Pezzullo J., Choucair W., Southard J., Kokkinos P., Karasik P., et al. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol 91 (2003) 1137-1140
343. Zughaib M.E., Tang X.L., Schleman M., Jeroudi M.O., and Bolli R. Beneficial effects of MDL 74,405, a cardioselective water soluble alpha tocopherol analogue, on the recovery of function of stunned myocardium in intact dogs. Cardiovasc Res 28 (1994) 235-241